IL6 and chronic obstructive pulmonary disease: TP-TR significantly improved pulmonary function in COPD rats, along with reduced levels of pro-inflammatory cytokines (such as IL-6, TNF-α), attenuated pulmonary infiltration, and decreased oxidative stress markers (e.g., MDA).